Placebo response in a double-blind therapeutic supplementation trial in stabilized outpatients with schizophrenia.
Dickerson
Faith B
FB
Boronow
John J
JJ
Stallings
Cassie R
CR
Lee
Beth A
BA
Agarwal
Rajni
R
Fenton
Wayne S
WS
Yolken
Robert H
RH
D004311:Double-Blind Method; D015118:Eicosapentaenoic Acid; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D006801:Humans; D012559:Schizophrenia / Q000628:therapy*
D005231:Fatty Acids, Unsaturated; D015118:Eicosapentaenoic Acid